Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.
MER Indicator |
MER description |
Target Fiscal Year |
Target |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female |
2016 |
1,314 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male |
2016 |
7,447 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female |
2016 |
8,077 |
HTS_TST |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male |
2016 |
25,533 |
HTS_TST |
By Test Result: Negative |
2016 |
40,398 |
HTS_TST |
Number of individuals who received T&C services for HIV and received their test results during the past 12 months |
2016 |
42,371 |
HTS_TST |
Sum of Aggregated Age/Sex <15 |
2016 |
8,761 |
HTS_TST |
Sum of Aggregated Age/Sex 15+ |
2016 |
33,610 |
HTS_TST |
Sum of Aggregated Age/Sex disaggregates |
2016 |
42,371 |
HTS_TST |
Sum of Test Result disaggregates |
2016 |
42,371 |
HTS_TST_POS |
By Test Result: Positive |
2016 |
1,973 |
KP_MAT |
Number of people who inject drugs (PWID) on medication assisted therapy (MAT) for at least 6 months |
2016 |
424 |
KP_MAT |
Sex: Female |
2016 |
34 |
KP_MAT |
Sex: Male |
2016 |
390 |
KP_MAT |
Sum of Sex disaggregates |
2016 |
424 |
KP_PREV |
By key population type: Females who inject drugs (Female PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2016 |
61 |
KP_PREV |
By key population type: Males who inject drugs (Male PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) |
2016 |
672 |
KP_PREV |
Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required |
2016 |
733 |
VMMC_CIRC |
By Age: 15-19 |
2016 |
51,114 |
VMMC_CIRC |
By Age: 20-24 |
2016 |
30,670 |
VMMC_CIRC |
By circumcision technique: Surgical VMMC |
2016 |
102,212 |
VMMC_CIRC |
By follow-up status: Number of surgically circumcised clients who did NOT return for follow-up care within 14 days of circumcision surgery |
2016 |
61,184 |
VMMC_CIRC |
By follow-up status: Number of surgically circumcised clients who returned at least once for follow-up care within 14 days of circumcision surgery |
2016 |
41,028 |
VMMC_CIRC |
By HIV status: Number of clients with undocumented/indeterminate HIV status or not tested for HIV at site |
2016 |
17,171 |
VMMC_CIRC |
By HIV status: Number of HIV-negative clients (tested HIV negative at VMMC program) |
2016 |
83,815 |
VMMC_CIRC |
By HIV status: Number of HIV-positive clients (tested HIV positive at VMMC site) |
2016 |
1,226 |
VMMC_CIRC |
Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period |
2016 |
102,212 |
VMMC_CIRC |
Sum of age disaggregates |
2016 |
81,784 |